Theorem Clinical Research

Theorem Clinical Research names Joseph Sgherza head of infectious diseases

Tuesday, October 1, 2013 09:44 AM

Global CRO Theorem Clinical Research has named Joseph Sgherza vice president of biopharmaceutical development for its infectious disease franchise. Sgherza has 24 years in the pharmaceutical, biotech and CRO industries.

More... »

Theorem, Charles River collaborate

Friday, September 13, 2013 01:17 PM

CROs Theorem Clinical Research and Charles River Laboratories are collaborating to provide clients with an integrated solution from nonclinical testing and analysis through clinical development and registration. The alliance provides nonclinical testing programs in bioanalysis, immunogenicity and immunology to support clinical trials.

More... »

Ximedica, Theorem collaborate

Friday, September 6, 2013 02:44 PM

Global CRO Theorem Clinical Research is collaborating with Ximedica, a medical product development firm.

More... »

Theorem, RadMD collaborate

Friday, August 16, 2013 11:44 AM

Theorem Clinical Research is collaborating with RadMD, a medical imaging company.

More... »

Theorem partners with Emergo for regulatory consulting

Tuesday, July 9, 2013 03:06 PM

CRO Theorem Clinical Research, based in King of Prussia, Penn., has formed a strategic partnership with Emergo Group to provide global regulatory consulting services, including reimbursement consultation and in-country regulatory representation services, to the medical device and in vitro diagnostics community. 

More... »

Wierman appointed Theorem vice president of biopharmaceutical development

Monday, May 13, 2013 08:00 AM

Theorem Clinical Research, a King of Prussia, Penn.-based, mid-sized provider of comprehensive clinical research and development services, has appointed Connie Wierman as vice president of biopharmaceutical development. Wierman leads the company’s oncology therapeutic focus for the biopharmaceutical business unit.

More... »

Theorem expands partnership with Medidata

Wednesday, March 13, 2013 11:08 AM

Theorem Clinical Research, a midsized full-service, global CRO, has expanded its Medidata services partnership by obtaining accreditation for Medidata Balance and Medidata Rave Targeted Source Document Verification (TSDV) services.

Medidata Balance accreditation enables Theorem to provide a unified approach to patient data capture and randomization. Clinical investigators and sponsors will gain immediate operational efficiencies while leveraging Theorem’s clinical expertise.

More... »

Theorem optimizes services for regulatory and clinical issues

Wednesday, October 10, 2012 09:22 AM

Theorem Clinical Research, a King of Prussia, Penn.-based full-service CRO that provides core clinical R&D services, also helps clients identify and strategically address early and ongoing device-related regulatory and clinical issues.

More... »

Theorem and Gallus ink exclusive partnership

Wednesday, August 8, 2012 10:15 AM

Theorem Clinical Research, a global provider of comprehensive clinical research and development services, has entered an exclusive partnership with Gallus BioPharmaceuticals, a contract manufacturing company based in St. Louis, Mo., to help both companies accelerate their research, development and manufacturing of biopharmaceuticals.

More... »

Theorem relocates headquarters to accommodate growth

Thursday, August 2, 2012 12:24 PM

Theorem Clinical Research, a midsize CRO that provides core clinical research and development services, has relocated its headquarters 1.5 miles from the original site in King of Prussia, Penn., where the company has been located for the past 10 years.

More... »